Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Inbal

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 1998
Recombinant von Willebrand factor fragment AR545C inhibits platelet aggregation and enhances thrombolysis with rtPA in a rabbit thrombosis modelO Gurevitz, A Goldfarb, H Hod, et al.
Blood|August 1, 1993
Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization methodA Inbal, T Englender, N Kornbrot, et al.
Journal of Thrombosis and Haemostasis : JTH|June 6, 2017
Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial resultsB A Kerlin, A Inbal, A Will, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolismO Salomon, N Rosenberg, A Zivelin, et al.
Thrombosis and Haemostasis|June 1, 1992
Characterization of three mutations causing von Willebrand disease type IIA in five unrelated familiesA Inbal, U Seligsohn, N Kornbrot, et al.
Thrombosis and Haemostasis|December 29, 2000
S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis modelO Gurevitz, M Eldar, E Skutelsky, et al.
Blood|March 26, 1999
Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young malesA Inbal, D Freimark, B Modan, et al.
American Journal of Medical Genetics|January 30, 1995
Myopathy, lactic acidosis, and sideroblastic anemia: a new syndromeA Inbal, N Avissar, M Shaklai, et al.
British Journal of Haematology|January 1, 1997
Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factorA Inbal, I Bank, A Zivelin, et al.
Blood|September 9, 1999
Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: in vitro and ex vivo inhibition of platelet functionA Inbal, O Gurevitz, I Tamarin, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 1998
Recombinant von Willebrand factor fragment AR545C inhibits platelet aggregation and enhances thrombolysis with rtPA in a rabbit thrombosis modelO Gurevitz, A Goldfarb, H Hod, et al.
Blood|August 1, 1993
Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization methodA Inbal, T Englender, N Kornbrot, et al.
Journal of Thrombosis and Haemostasis : JTH|June 6, 2017
Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial resultsB A Kerlin, A Inbal, A Will, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolismO Salomon, N Rosenberg, A Zivelin, et al.
Thrombosis and Haemostasis|June 1, 1992
Characterization of three mutations causing von Willebrand disease type IIA in five unrelated familiesA Inbal, U Seligsohn, N Kornbrot, et al.
Thrombosis and Haemostasis|December 29, 2000
S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis modelO Gurevitz, M Eldar, E Skutelsky, et al.
Blood|March 26, 1999
Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young malesA Inbal, D Freimark, B Modan, et al.
American Journal of Medical Genetics|January 30, 1995
Myopathy, lactic acidosis, and sideroblastic anemia: a new syndromeA Inbal, N Avissar, M Shaklai, et al.
British Journal of Haematology|January 1, 1997
Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factorA Inbal, I Bank, A Zivelin, et al.
Blood|September 9, 1999
Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: in vitro and ex vivo inhibition of platelet functionA Inbal, O Gurevitz, I Tamarin, et al.
Pageof 7